Genetically engineered K562 cells augment NK cell cytotoxicity against acute myeloid leukemia and reduce dependency on IL-15. - Akhkand SS; Soleimani M; Zomorrod MS; Kiani J (Medical oncology (Northwood, London, England), 2025)